Michael Graves - Oct 27, 2023 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Director
Signature
/s/ Scott Tarriff, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Oct 27, 2023
Transactions value $
$46,238
Form type
4
Date filed
10/31/2023, 05:41 PM
Previous filing
Mar 9, 2023
Next filing
Dec 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Options Exercise $46.2K +9.36K +936% $4.94 10.4K Oct 27, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EGRX Stock Option (right to buy) Options Exercise $0 -9.36K -100% $0.00* 0 Oct 27, 2023 Common Stock 9.36K $4.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.